posted on 2014-01-27, 03:30authored byPleunie van den Borne, Sander W. van der Laan, Sandra M. Bovens, Dave Koole, Mark C. Kowala, Laura F. Michael, Arjan H. Schoneveld, Sander M. van de Weg, Evelyn Velema, Jean-Paul de Vries, Gert J. de Borst, Frans L. Moll, Dominique P. V. de Kleijn, Paul H. A. Quax, Imo E. Hoefer, Gerard Pasterkamp
Validation of ex vivo LTB4 production after whole blood collection by EDTA (black bars, n = 4, duplo) or Sodium Citrate (white bars, n = 4, duplo) Vacutainers. Directly after collection, whole blood was incubated with a specific 5-LOX inhibitor Zileuton (100 µM for 30 minutes) and plasma was stored. LTB4 was measured using ELISA and compared with levels of CEA patients (n = 35). Data is expressed as mean ± standard deviation and in pg/ml.